Complete Filing Data
AVENUE THERAPEUTICS, INC. reported Stockholders Equity of $1.83 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean AVENUE THERAPEUTICS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.9M | -$11.7M | -$10.5M | -$3.6M | -$3.7M | -$5.2M | -$25.9M | -$21.5M | -$12.3M | -$3.2M | -$5.2M |
| Research And Development Expense | $1.0M | $6.6M | $6.1M | $2.7M | $1.3M | $2.9M | $22.2M | $17.7M | $6.7M | $1.3M | $961.0K |
| Operating Income Loss | -$3.1M | -$11.3M | -$14.5M | -$8.0M | -$3.7M | -$5.2M | -$26.3M | -$21.8M | -$11.4M | -$2.4M | -$4.8M |
| General And Administrative Expense | $3.7M | $4.6M | $4.2M | $5.3M | $2.5M | $2.3M | $3.1M | $4.1M | $3.6M | $997.0K | $842.0K |
| Net Income Loss Attributable To Noncontrolling Interest | -$38.0K | -$44.0K | -$111.0K | -$51.0K | $0.00 | ||||||
| Net Income Loss Available To Common Stockholders Basic | -$11.7M | -$10.4M | -$3.6M | ||||||||
| Nonoperating Income Expense | |||||||||||
| Interest Expense Related Party | $0.00 | $81.0K | $192.0K | $168.0K | |||||||
| Interest Expense | $0.00 | $294.0K | $420.0K | $215.0K | |||||||
| Research And Development Expense For Licenses Acquired | $0.00 | $4.2M | $0.00 | ||||||||
| Revenues | $1.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$683.0K | $335.0K | -$1.9M | -$3.1M | -$2.7M | -$4.3M | $526.0K | -$4.0M | -$7.6M | -$662.0K | -$604.0K | -$2.9M | -$871.0K | -$949.0K | -$998.0K | -$1.0M | -$1.9M | -$1.2M | -$2.2M | -$7.0M | -$11.3M | -$2.6M | -$4.7M | -$10.4M | -$6.2M | -$2.9M | -$2.4M | -$661.0K | -$815.0K | -$544.0K | -$771.0K | -$1.0M |
| Research And Development Expense | $177.0K | $192.0K | $411.0K | $2.3M | $1.4M | $2.4M | $907.0K | $3.0M | $1.2M | $194.0K | $151.0K | $1.8M | $278.0K | $328.0K | $258.0K | $466.0K | $1.2M | $697.0K | $1.7M | $6.4M | $10.2M | $1.8M | $3.8M | $9.4M | $2.0M | $447.0K | $133.0K | $183.0K | $421.0K | $564.0K | ||
| Operating Income Loss | -$724.0K | $297.0K | -$1.9M | -$3.2M | -$2.8M | -$3.7M | -$2.1M | -$3.9M | -$6.4M | -$663.0K | -$605.0K | -$2.9M | -$872.0K | -$951.0K | -$1.0M | -$1.0M | -$1.9M | -$1.3M | -$2.3M | -$7.1M | -$11.4M | -$2.6M | -$4.7M | -$10.4M | -$2.8M | -$1.7M | -$504.0K | -$383.0K | -$638.0K | -$840.0K | ||
| General And Administrative Expense | $547.0K | $915.0K | $1.5M | $829.0K | $1.5M | $1.3M | $1.2M | $896.0K | $984.0K | $469.0K | $454.0K | $1.1M | $594.0K | $623.0K | $743.0K | $571.0K | $684.0K | $577.0K | $617.0K | $716.0K | $1.1M | $820.0K | $927.0K | $986.0K | $848.0K | $1.3M | $371.0K | $200.0K | $217.0K | $276.0K | ||
| Net Income Loss Attributable To Noncontrolling Interest | -$9.0K | -$6.0K | -$6.0K | -$11.0K | -$9.0K | -$9.0K | -$13.0K | -$9.0K | -$66.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$683.0K | $335.0K | -$3.1M | -$7.2M | -$4.3M | $526.0K | -$4.0M | -$7.5M | -$662.0K | -$604.0K | -$2.9M | |||||||||||||||||||||
| Nonoperating Income Expense | $32.0K | $32.0K | $47.0K | $69.0K | $122.0K | -$641.0K | $2.6M | -$93.0K | -$1.2M | $1.0K | $1.0K | $2.0K | ||||||||||||||||||||
| Interest Expense Related Party | $0.00 | $0.00 | $0.00 | $0.00 | $20.0K | $61.0K | $53.0K | $46.0K | $33.0K | |||||||||||||||||||||||
| Interest Expense | $0.00 | $0.00 | $0.00 | $106.0K | $93.0K | $95.0K | $89.0K | $87.0K | $85.0K | |||||||||||||||||||||||
| Research And Development Expense For Licenses Acquired | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.2M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||
| Revenues | $0.00 | $1.4M | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.8M | $2.8M | $1.6M | $3.9M | $3.5M | $2.4M | $6.8M | -$631.0K | $19.4M | -$8.2M | -$5.1M |
| Cash And Cash Equivalents At Carrying Value | $2.9M | $2.6M | $1.8M | $6.7M | $3.8M | $3.1M | $8.7M | $2.7M | $197.0K | $14.0K | |
| Retained Earnings Accumulated Deficit | -$105.5M | -$102.6M | -$90.9M | -$80.6M | -$77.0M | -$73.3M | -$68.1M | -$42.2M | -$20.7M | -$8.4M | |
| Liabilities Current | $1.1M | $816.0K | $1.2M | $3.6M | $509.0K | $886.0K | $2.1M | $5.2M | $2.8M | $6.4M | |
| Liabilities And Stockholders Equity | $2.9M | $2.7M | $1.9M | $6.8M | $4.0M | $3.2M | $8.9M | $4.5M | $22.2M | $197.0K | |
| Liabilities | $1.1M | $816.0K | $1.2M | $3.6M | $509.0K | $886.0K | $2.1M | $5.2M | $2.8M | $8.4M | |
| Assets | $2.9M | $2.7M | $1.9M | $6.8M | $4.0M | $3.2M | $8.9M | $4.5M | $22.2M | $197.0K | |
| Common Stock Value | $0.00 | $0.00 | $3.0K | $0.00 | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | ||
| Prepaid Expense And Other Assets Current | $76.0K | $78.0K | $67.0K | $137.0K | $107.0K | $113.0K | $170.0K | $152.0K | $388.0K | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.7M | $3.8M | $3.1M | $8.7M | $2.7M | $11.8M | |||||
| Accounts Payable And Accrued Liabilities Current | $451.0K | $857.0K | $1.1M | $4.7M | $2.7M | $506.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $261.0K | $811.0K | -$4.9M | $2.9M | $631.0K | -$5.6M | $6.1M | -$9.1M | |||
| Additional Paid In Capital Common Stock | $84.5M | $80.5M | $75.6M | $74.9M | $41.6M | $38.9M | $105.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.9M | $2.6M | $1.8M | $6.7M | $3.8M | ||||||
| Accounts Payable And Accrued Expenses Related Party Current | $21.0K | $58.0K | $29.0K | $14.0K | $487.0K | $53.0K | $1.3M | ||||
| Adjustments To Additional Paid In Capital And Noncontrolling Interest From Subsidiary Equity Issuance | $0.00 | $0.00 | $0.00 | ||||||||
| Minority Interest | $0.00 | -$941.0K | -$928.0K | -$639.0K | |||||||
| Fair Value Adjustments Of Convertible Notes Payable | $0.00 | $99.0K | $0.00 | $0.00 | |||||||
| Loss On Warrant Liabilities Classified As Inducement Fee | $0.00 | $759.0K | $0.00 | ||||||||
| Financing Costs Warrant Liabilities | $0.00 | $332.0K | $1.2M | ||||||||
| Derivative Liabilities Current | $1.0K | $16.0K | $586.0K | $2.6M | |||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Cash Period Increase Decrease | -$9.1M | $11.6M | $183.0K | $14.0K | |||||||
| Common Stock Issued To Fortress Value | $55.0K | $827.0K | $72.0K | $0.00 | |||||||
| Amortization Of Debt Discount Premium | $0.00 | $174.0K | $123.0K | $73.0K | |||||||
| Accrued Interest Related Party | $0.00 | -$46.0K | $181.0K | $165.0K | |||||||
| Common Stock Value Issuable | $0.00 | $1.1M | $49.0K | ||||||||
| Common Stock Shares Issuable | 0.00 | 273.8K | 83.5K | ||||||||
| Short Term Investments | $0.00 | $10.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $3.6M | $4.1M | $3.5M | $2.6M | $4.8M | $2.8M | -$3.7M | -$5.3M | -$1.5M | -$39.0K | $598.0K | $1.2M | -$160.0K | $642.0K | $1.5M | $2.4M | $3.2M | $4.1M | $5.8M | $12.0M | $13.9M | $20.4M | $2.8M | $5.0M | $9.4M | $24.2M | $27.2M | -$8.9M | |||||||
| Cash And Cash Equivalents At Carrying Value | $3.7M | $3.3M | $3.5M | $2.6M | $4.9M | $3.2M | $161.0K | $1.6M | $8.2M | $217.0K | $890.0K | $1.8M | $585.0K | $1.1M | $1.8M | $4.3M | $5.3M | $6.6M | $8.7M | $10.5M | $29.4M | $4.8M | $8.9M | $15.0M | $11.8M | $16.1M | $34.7M | $0.00 | $30.0K | ||||||
| Retained Earnings Accumulated Deficit | -$104.8M | -$104.1M | -$104.4M | -$101.0M | -$98.0M | -$95.3M | -$91.6M | -$92.1M | -$88.1M | -$81.1M | -$80.5M | -$79.9M | -$76.1M | -$75.2M | -$74.3M | -$72.3M | -$71.2M | -$69.4M | -$62.7M | -$60.5M | -$53.5M | -$38.3M | -$35.7M | -$31.0M | -$14.4M | -$11.5M | -$9.1M | ||||||||
| Liabilities Current | $1.4M | $1.3M | $1.3M | $973.0K | $1.2M | $1.4M | $5.0M | $7.8M | $10.6M | $614.0K | $407.0K | $797.0K | $848.0K | $549.0K | $469.0K | $1.1M | $1.2M | $923.0K | $1.9M | $1.8M | $9.4M | $2.5M | $4.4M | $5.9M | $2.0M | $7.2M | $7.8M | ||||||||
| Liabilities And Stockholders Equity | $3.7M | $4.2M | $3.6M | $2.6M | $5.0M | $3.3M | $502.0K | $1.7M | $8.4M | $575.0K | $1.0M | $2.0M | $688.0K | $1.2M | $1.9M | $4.4M | $5.3M | $6.7M | $13.9M | $15.7M | $29.8M | $5.3M | $9.4M | $15.3M | $26.2M | $34.7M | $234.0K | ||||||||
| Liabilities | $1.4M | $1.3M | $1.3M | $973.0K | $1.2M | $1.4M | $5.0M | $7.8M | $10.6M | $614.0K | $407.0K | $797.0K | $848.0K | $549.0K | $469.0K | $1.1M | $1.2M | $923.0K | $1.9M | $1.8M | $9.4M | $2.5M | $4.4M | $5.9M | $2.0M | $7.5M | $9.1M | ||||||||
| Assets | $3.7M | $4.2M | $3.6M | $2.6M | $5.0M | $3.3M | $502.0K | $1.7M | $8.4M | $575.0K | $1.0M | $2.0M | $688.0K | $1.2M | $1.9M | $4.4M | $5.3M | $6.7M | $13.9M | $15.7M | $29.8M | $5.3M | $9.4M | $15.3M | $26.2M | $34.7M | $234.0K | ||||||||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | ||||||||
| Prepaid Expense And Other Assets Current | $16.0K | $35.0K | $92.0K | $28.0K | $69.0K | $116.0K | $18.0K | $69.0K | $198.0K | $20.0K | $115.0K | $123.0K | $29.0K | $70.0K | $119.0K | $27.0K | $74.0K | $122.0K | $76.0K | $161.0K | $254.0K | $459.0K | $496.0K | $310.0K | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $217.0K | $890.0K | $1.8M | $585.0K | $1.1M | $1.8M | $4.3M | $5.3M | $6.6M | $8.7M | $10.5M | $29.4M | $4.8M | $8.9M | |||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $1.5M | $886.0K | $1.8M | $949.0K | $573.0K | $397.0K | $746.0K | $672.0K | $416.0K | $389.0K | $1.1M | $1.2M | $790.0K | $1.9M | $1.7M | $9.3M | $2.1M | $4.2M | $5.8M | $1.9M | $826.0K | $868.0K | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $908.0K | $1.4M | $1.5M | -$1.9M | -$1.3M | -$2.2M | $26.8M | ||||||||||||||||||||||||||||
| Additional Paid In Capital Common Stock | $81.1M | $81.1M | $81.0M | $75.9M | $75.9M | $75.7M | $75.5M | $75.3M | $75.1M | $74.7M | $74.4M | $73.8M | $41.1M | $40.7M | $40.4M | $38.6M | $38.6M | $159.0K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $3.7M | $3.3M | $3.5M | $2.6M | $4.9M | $3.2M | $161.0K | $1.6M | $8.2M | $217.0K | $890.0K | $1.8M | |||||||||||||||||||||||
| Accounts Payable And Accrued Expenses Related Party Current | $41.0K | $10.0K | $51.0K | $176.0K | $133.0K | $80.0K | $31.0K | $37.0K | $133.0K | $16.0K | $45.0K | $86.0K | $371.0K | $185.0K | $167.0K | $76.0K | |||||||||||||||||||
| Adjustments To Additional Paid In Capital And Noncontrolling Interest From Subsidiary Equity Issuance | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Minority Interest | -$1.3M | -$1.2M | -$1.2M | -$958.0K | -$937.0K | -$938.0K | -$872.0K | -$810.0K | -$705.0K | ||||||||||||||||||||||||||
| Fair Value Adjustments Of Convertible Notes Payable | $0.00 | $0.00 | $0.00 | $0.00 | $95.0K | $4.0K | $0.00 | $0.00 | $89.0K | ||||||||||||||||||||||||||
| Loss On Warrant Liabilities Classified As Inducement Fee | $0.00 | $0.00 | $0.00 | $0.00 | $185.0K | $574.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||
| Financing Costs Warrant Liabilities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $332.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||
| Derivative Liabilities Current | $2.0K | $0.00 | $1.0K | $29.0K | $47.0K | $413.0K | $3.3M | $5.9M | $5.7M | ||||||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Cash Period Increase Decrease | $26.8M | $3.2M | -$197.0K | -$2.0K | |||||||||||||||||||||||||||||||
| Common Stock Issued To Fortress Value | $55.0K | $371.0K | $72.0K | ||||||||||||||||||||||||||||||||
| Amortization Of Debt Discount Premium | $0.00 | $33.0K | $29.0K | ||||||||||||||||||||||||||||||||
| Accrued Interest Related Party | $0.00 | $58.0K | $29.0K | ||||||||||||||||||||||||||||||||
| Common Stock Value Issuable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||
| Common Stock Shares Issuable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||||||||||
| Short Term Investments | $5.0M | $5.0M | $0.00 | $0.00 | $0.00 | $10.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $2.1M | $9.8M | $7.5M | $10.5M | $4.4M | $0.00 | $32.3M | -$895.0K | $28.4M | $1.8M | $3.9M |
| Operating Cash Flow * | -$1.8M | -$9.0M | -$9.5M | -$7.6M | -$3.8M | -$4.6M | -$26.3M | -$18.2M | -$6.8M | -$1.6M | -$895.0K |
| Share Based Compensation | $665.0K | $1.2M | $906.0K | $649.0K | $442.0K | $710.0K | $1.8M | $1.5M | $604.0K | $28.0K | $29.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.0K | $11.0K | -$70.0K | $30.0K | -$6.0K | -$57.0K | $18.0K | -$236.0K | $388.0K | $0.00 | $0.00 |
| Increase Decrease In Due To Related Parties | -$37.0K | $29.0K | $15.0K | -$473.0K | $434.0K | $337.0K | $829.0K | $511.0K | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $385.0K | -$406.0K | -$244.0K | -$2.8M | $1.1M | $2.2M | $15.0K | $491.0K | |||
| Net Cash Provided By Used In Investing Activities | $0.00 | -$3.0M | $0.00 | -$1.0M | $0.00 | $10.0M | -$10.0M | $0.00 | -$3.0M | ||
| Stock Issued During Period Value Share Based Compensation | $649.0K | $442.0K | $710.0K | $1.8M | $1.5M | ||||||
| Proceeds From Issuance Of Common Stock | $2.1M | $1.6M | $0.00 | $5.0M | $0.00 | $35.0M | $0.00 | $38.0M | $0.00 | $0.00 | |
| Payments Of Stock Issuance Costs | $508.0K | $663.0K | $0.00 | $2.7M | $895.0K | $3.7M | |||||
| Proceeds From Warrant Exercises | $0.00 | $9.4M | $1.0K | $148.0K | |||||||
| Payments To Acquire Investments | $0.00 | $5.0M | $0.00 | $10.0M | $0.00 | $0.00 | |||||
| Increase Decrease In Interest Payable Net | $0.00 | -$57.0K | $57.0K | $0.00 | |||||||
| Payments Of Warrants Exercise Transaction Costs | $0.00 | $1.2M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $2.1M | $4.5M | $3.1M | $0.00 | $32.3M | $0.00 | -$163.0K | $875.0K | |||||||||||
| Operating Cash Flow * | -$1.2M | -$3.1M | -$1.6M | -$1.9M | -$1.3M | -$1.2M | -$5.6M | -$6.8M | -$34.0K | -$877.0K | |||||||||
| Share Based Compensation | $185.0K | $191.0K | $11.0K | $569.0K | $114.0K | $215.0K | $751.0K | $350.0K | $5.0K | $9.0K | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $14.0K | $49.0K | $61.0K | $16.0K | $6.0K | -$48.0K | $102.0K | -$78.0K | $0.00 | ||||||||||
| Increase Decrease In Due To Related Parties | -$7.0K | $51.0K | $119.0K | -$401.0K | $114.0K | $220.0K | $206.0K | ||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $295.0K | -$468.0K | -$311.0K | $5.5M | $3.0M | $362.0K | -$192.0K | ||||||||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | -$1.0M | $0.00 | $10.0M | $0.00 | ||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $25.0K | $43.0K | $569.0K | $69.0K | $116.0K | $114.0K | $161.0K | $216.0K | $215.0K | $299.0K | $535.0K | $751.0K | $372.0K | ||||||
| Proceeds From Issuance Of Common Stock | $2.1M | $0.00 | $35.0M | $0.00 | |||||||||||||||
| Payments Of Stock Issuance Costs | $2.7M | $0.00 | |||||||||||||||||
| Proceeds From Warrant Exercises | $0.00 | $5.0M | $0.00 | ||||||||||||||||
| Payments To Acquire Investments | $5.0M | ||||||||||||||||||
| Increase Decrease In Interest Payable Net | $0.00 | -$52.0K | $0.00 | ||||||||||||||||
| Payments Of Warrants Exercise Transaction Costs | $0.00 | $442.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.22 | -$0.31 | -$1.65 | -$2.10 | -$1.85 | -$1.11 | -$1.93 | ||||
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 75.0M | 20.0M | 20.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 3.2M | 2.1M | 341.3K | 4.8M | 1.4M | 16.7M | 16.7M | 10.7M | 10.3M | 3.3M | |
| Common Stock Shares Issued | 3.2M | 2.1M | 341.3K | 4.8M | 4.8M | 16.7M | 16.7M | 10.7M | 10.3M | 3.3M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 16.5M | 15.7M | 10.2M | 6.6M | 2.9M | 2.7M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 3.1M | 1.3M | 141.2K | 2.2M | 1.1M | 16.5M | |||||
| Earnings Per Share Basic | $-0.93 | $-15.79 | $-73.48 | $-1.63 | $-0.22 | $-0.31 | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 2.2M | 1.1M | 16.5M | ||||||||
| Preferred Stock Shares Outstanding | 250.0K | 250.0K | 250.0K | 250.0K | |||||||
| Preferred Stock Shares Issued | 250.0K | 250.0K | 250.0K | 250.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.06 | -$0.45 | -$0.03 | -$0.14 | -$0.79 | -$0.06 | -$0.06 | -$0.06 | -$0.11 | -$0.08 | -$0.14 | -$0.43 | -$0.82 | -$0.25 | -$0.45 | -$1.03 | -$0.63 | -$0.30 | -$0.70 | -$0.22 | -$0.27 | -$0.19 | -$0.28 | -$0.13 | ||||||||||
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | |||||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 75.0M | 75.0M | 75.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | ||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Outstanding | 3.2M | 3.2M | 3.2M | 1.6M | 1.2M | 590.2K | 9.0M | 7.9M | 6.8M | 1.5M | 22.1M | 22.1M | 16.8M | 16.7M | 16.7M | 16.7M | 16.7M | 16.7M | 16.7M | 16.6M | 16.6M | 10.7M | 10.6M | 10.6M | 10.3M | 10.0M | 10.0M | |||||||
| Common Stock Shares Issued | 3.2M | 3.2M | 3.2M | 1.6M | 1.2M | 590.2K | 9.0M | 7.9M | 6.8M | 1.5M | 22.1M | 22.1M | 16.8M | 16.7M | 16.7M | 16.7M | 16.7M | 16.7M | 16.7M | 16.6M | 16.6M | 10.7M | 10.6M | 10.6M | 10.3M | 10.0M | 10.0M | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 16.6M | 16.6M | 16.5M | 16.5M | 16.5M | 16.4M | 16.3M | 13.7M | 10.3M | 10.3M | 10.1M | 10.0M | 3.5M | 3.0M | 2.8M | 2.8M | 8.3M | |||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 3.2M | 3.2M | 3.0M | 1.6M | 1.1M | 562.0K | 108.2K | 103.4K | 74.2K | 1.5M | 21.9M | 1.4M | 1.1M | 16.6M | 16.6M | 16.5M | ||||||||||||||||||
| Earnings Per Share Basic | $-0.21 | $-0.62 | $-1.92 | $-6.43 | $-15.40 | $4.86 | $-38.74 | $-101.57 | $-0.45 | $-0.41 | $-2.05 | $-0.79 | $-0.06 | $-0.06 | $-0.06 | |||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 8.2M | 1.5M | 21.9M | 21.0M | 1.1M | 16.6M | 16.6M | 16.5M | ||||||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | ||||||||||||||||||||||||
| Preferred Stock Shares Issued | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $121.0K | $176.0K | $126.0K | $20.0K | $7.0K | $62.0K | $357.0K | $93.0K | $88.0K | $0.00 | $0.00 |
| Fair Value Adjustment Of Warrants | -$15.0K | -$170.0K | -$4.3M | -$5.6M | $0.00 | $0.00 | $451.0K | $188.0K | $0.00 | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $665.0K | $1.2M | $906.0K | $649.0K | $1.5M | $604.0K | $28.0K | $29.0K | |||
| Stock Issued During Period Value New Issues | $55.0K | $827.0K | $72.0K | $0.00 | $948.0K | $5.0K | |||||
| Issuance Of Stock Under Founders Agreement | $76.0K | -$167.0K | $371.0K | $526.0K | |||||||
| Additional Paid In Capital | $107.3M | $105.4M | $92.5M | $84.5M | |||||||
| Stock Issued During Period Value Exercise0f Warrants | $9.4M | $1.0K | $237.0K | ||||||||
| Stock Issued1 | $55.0K | $827.0K | $0.00 | $0.00 | $0.00 | $1.0K | |||||
| Common Shares Issuable Founders Agreement | 76.0K | -167.0K | 371.0K | 526.0K | |||||||
| Issuance Of Stock For Licenses Acquired | $0.00 | $1.2M | $0.00 | ||||||||
| Share Issued During Period Value Warrants Exercised | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $34.0K | $31.0K | $32.0K | $51.0K | $52.0K | $49.0K | $9.0K | $57.0K | $37.0K | $1.0K | $1.0K | $2.0K | $1.0K | $2.0K | $3.0K | $9.0K | $15.0K | $32.0K | $81.0K | $126.0K | $91.0K | $13.0K | $24.0K | $48.0K | $6.0K | $0.00 | $0.00 | $0.00 | ||
| Fair Value Adjustment Of Warrants | $2.0K | -$1.0K | -$15.0K | -$18.0K | -$255.0K | $116.0K | -$2.6M | $150.0K | $878.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $454.0K | -$3.0K | $19.0K | $0.00 | $0.00 | |||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $163.0K | $175.0K | $185.0K | $331.0K | $192.0K | $191.0K | $561.0K | $27.0K | $11.0K | $25.0K | $43.0K | $569.0K | $535.0K | $751.0K | $321.0K | $350.0K | $5.0K | |||||||||||||
| Stock Issued During Period Value New Issues | $55.0K | $172.0K | $371.0K | $72.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||
| Issuance Of Stock Under Founders Agreement | $0.00 | -$363.0K | $0.00 | $0.00 | ||||||||||||||||||||||||||
| Additional Paid In Capital | $108.3M | $108.2M | $107.9M | $103.6M | $102.7M | $98.1M | $87.9M | $86.8M | $86.6M | |||||||||||||||||||||
| Stock Issued During Period Value Exercise0f Warrants | $0.00 | $4.4M | $5.3M | $0.00 | $0.00 | |||||||||||||||||||||||||
| Stock Issued1 | $55.0K | $371.0K | $0.00 | |||||||||||||||||||||||||||
| Common Shares Issuable Founders Agreement | 14.0K | -8.0K | -363.0K | |||||||||||||||||||||||||||
| Issuance Of Stock For Licenses Acquired | $0.00 | $1.2M | $0.00 | |||||||||||||||||||||||||||
| Share Issued During Period Value Warrants Exercised | $0.00 | $0.00 | $0.00 | $0.00 |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.